tiprankstipranks
Advertisement
Advertisement
Ab Science’s Phase 3 ALS Trial: A Key Development for Investors
PremiumCompany AnnouncementsAb Science’s Phase 3 ALS Trial: A Key Development for Investors
11M ago
AB Science Reports Reduced Deficit and Clinical Progress
Premium
Company Announcements
AB Science Reports Reduced Deficit and Clinical Progress
1y ago
AB Science announces publication of results for masitinib
Premium
The Fly
AB Science announces publication of results for masitinib
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100